NASDAQ:NGM NGM Biopharmaceuticals, Inc
I exited NGM for a 26% gain yesterday and re-entered today at $12.80. The stock appears to found a new channel following the release of interim phase 2 NASH data. This trade involves chart patterns and fundamentals. NGM is backed by Column Group L.P and Merck ( MRK ). Their data was positive. The float is very low and locked up by the above NGM shareholders. Should bounce to ~$14.0. Could break out to the $16.0 range.